• by bcarlson@marketresearch.com
  • March 25 2014


6 Breakthroughs in Cancer Tech: Kalorama in MD+DI Magazine

6 Breakthroughs in Cancer Tech: Kalorama in MD+DI Magazine

Digital PCR, Next-Gen, MS - these and other technologies will transform cancer testing.  Or so we report in an article written for MD+DI magazine.  How do we know this?  Because they are succeeding at the research level, it’s likely that many or all of the six crosses into clinical practice.   But manufacturers have to figure out how to prove their tests will have clinical usefulness.

As we say in the article:

It should not be surprising that the most strenuous efforts in medical science are aimed at the disease that is the No. 2 killer in the world. Cancer killed more than 7 million people worldwide in 2010, according to a report from the American Cancer Society; that’s more than AIDS, malaria, and tuberculosis combined. It is second only to heart disease as the leading cause of death across the globe. Absent a change, the number of annual cancer deaths could reach 13.2 million by 2030.

The article is based on our report on Cancer Diagnostics - where we make specific projections about cancer testing markets - available here: